Bristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Boosts FY16 Outlook
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.07 +0.02%
EPS Growth %: +5.5%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +5.5%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.74, $0.09 better than the analyst estimate of $0.65. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.19 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2016 EPS of $2.50-$2.60, versus the consensus of $2.40.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026
- Rubico to shift from semi-annual to quarterly financial reporting
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
